BriaCell Therapeutics (BCTXF) News Today $3.65 -0.32 (-8.06%) As of 03/31/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period BriaCell says second DSMB recommends continuation of Phase 3 study in MBCMarch 21, 2025 | markets.businessinsider.comBriaCell Therapeutics Shares Hit Record Low After Public Offering NewsFebruary 3, 2025 | marketwatch.comBriaCell announces common stock offering, no amount givenFebruary 3, 2025 | markets.businessinsider.comBriaCell Therapeutics trading halted, news pendingJanuary 28, 2025 | markets.businessinsider.comBriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025January 3, 2025 | globenewswire.comBriaCell Announces Proposed Effective Date of Share ConsolidationJanuary 3, 2025 | globenewswire.comInsider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40mDecember 19, 2024 | finance.yahoo.comBriaCell Therapeutics Reports Quarterly Financial LossDecember 17, 2024 | markets.businessinsider.comPromising Phase 2 Results and Safety Profile Justify Buy Rating for BriaCell TherapeuticsDecember 12, 2024 | markets.businessinsider.comBriaCell Prices 7.4 Mln Public Offering, To Raise $5.5 MlnDecember 12, 2024 | markets.businessinsider.comBriaCell Therapeutics: Promising Developments in Cancer Treatment and Positive OutlookDecember 3, 2024 | markets.businessinsider.comBriaCell’s Phase 3 Study Progresses in Cancer FightDecember 3, 2024 | markets.businessinsider.comBriaCell Unveils Promising Cancer Therapy DataNovember 4, 2024 | markets.businessinsider.comBriaCell reports survival data from Phase 2 studyOctober 22, 2024 | msn.comBriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing ConcernsOctober 22, 2024 | seekingalpha.comBriaCell’s Bria-IMT Regimen Shows Promise for Metastatic Breast Cancer with Brain Metastasis: A Buy RecommendationOctober 3, 2024 | markets.businessinsider.comBriaCell Therapeutics Raises $8.5M After Positive Results for Experimental Cancer TherapySeptember 19, 2024 | msn.comBriaCell falls on $5M stock offeringMay 15, 2024 | msn.comBriaCell Therapeutics Corp Ordinary Shares - New BCTApril 21, 2024 | morningstar.comBriaCell’s Shareholders Approve Directors and AuditorsFebruary 2, 2024 | msn.comBriaCell Therapeutics Corp.: BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast CancerJanuary 4, 2024 | finanznachrichten.deMiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual MeetingNovember 15, 2023 | businesswire.comBriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateOctober 25, 2023 | finance.yahoo.comOctober is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyOctober 20, 2023 | finance.yahoo.comClosing Bell: Briacell Therapeutics Corp flat on Monday (BCT)September 26, 2023 | theglobeandmail.comBriaCell Therapeutics: Poised To Move To Advanced Trials, But An Unconvincing ThesisSeptember 10, 2023 | msn.comBriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast CancerSeptember 8, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. Announces Voting Results From Special MeetingAugust 18, 2023 | finance.yahoo.comBriaCell receives NCI grant for cancer platform developmentAugust 17, 2023 | msn.comBriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)July 22, 2023 | theglobeandmail.comBriaCell Therapeutics (BCT) Gets a Buy Rating from H.C. WainwrightJune 28, 2023 | markets.businessinsider.comBriaCell Therapeutics in Definitive Agreement to Spin Off Certain AssetsMay 25, 2023 | marketwatch.comBriaCell to spin out BriaPro TherapeuticsMay 25, 2023 | msn.comBriaCell Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BCT)April 27, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Thursday (BCT)April 7, 2023 | theglobeandmail.comToronto Stocks Advance as Banking Sector Sentiment Improves; BriaCell Slides on Spinoff PlansApril 1, 2023 | morningstar.comBriaCell Therapeutics to Spin Off Certain AssetsMarch 30, 2023 | marketwatch.comBriaCell Sees Positive Survival Data in Ongoing TrialFebruary 23, 2023 | marketwatch.comBriaCell Reports Positive Survival Data in Advanced Metastatic Breast CancerFebruary 23, 2023 | finance.yahoo.comBriaCell to Investigate Potential Stock ManipulationJanuary 23, 2023 | marketwatch.comBriaCell Announces New Patent Issuance, Bria-OTS(TM) IND Timing Guidance, and Additional Clinical Sites to Boost EnrolmentJanuary 12, 2023 | stockhouse.comBriaCell to get US, Australian patent linked to personalized cancer immunotherapyJanuary 10, 2023 | msn.comBriaCell signs exclusive licensing deal with UMBC for cancer treatment candidateAugust 5, 2022 | bizjournals.comBriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this yearJuly 21, 2022 | finance.yahoo.comBriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer ImmunotherapyJuly 5, 2022 | nz.finance.yahoo.comWe're Hopeful That BriaCell Therapeutics (TSE:BCT) Will Use Its Cash WiselyMay 6, 2022 | nz.finance.yahoo.comWhy BriaCell Therapeutics Stock Is Surging TodayApril 13, 2022 | msn.comBriaCell gains on FDA fast track nod for its targeted breast cancer immunotherapy Bria-IMTApril 13, 2022 | seekingalpha.comWhy BriaCell Therapeutics Is Rising In Pre-market?April 13, 2022 | nasdaq.comBriaCell Adds Two Clinical Trial Sites to Accelerate Patient EnrollmentFebruary 28, 2022 | finance.yahoo.com Remove Ads Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter. Email Address BCTXF Media Mentions By Week BCTXF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTXF News Sentiment▼0.000.78▲Average Medical News Sentiment BCTXF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTXF Articles This Week▼00▲BCTXF Articles Average Week Remove Ads Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Spruce Biosciences News Today ImmunoPrecise Antibodies News Today Leap Therapeutics News Today Trinity Biotech News Today Athira Pharma News Today COSCIENS Biopharma News Today Eagle Pharmaceuticals News Today Aprea Therapeutics News Today TherapeuticsMD News Today Moleculin Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BCTXF) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCTXF Stock Free BCTXF Stock Alerts